Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FBXO45 anticorps (AA 83-115)

Cet anticorps Lapin Polyclonal détecte spécifiquement FBXO45 dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN6243827

Aperçu rapide pour FBXO45 anticorps (AA 83-115) (ABIN6243827)

Antigène

Voir toutes FBXO45 Anticorps
FBXO45 (F-Box Protein 45 (FBXO45))

Reactivité

  • 2
  • 2
  • 2
Humain

Hôte

  • 3
Lapin

Clonalité

  • 3
Polyclonal

Conjugué

  • 3
Cet anticorp FBXO45 est non-conjugé

Application

  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB53750
  • Épitope

    • 1
    • 1
    AA 83-115

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This FBXO45 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 83-115 amino acids from human FBXO45.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:2000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Antigène

    FBXO45 (F-Box Protein 45 (FBXO45))

    Autre désignation

    FBXO45

    Sujet

    Component of E3 ubiquitin ligase complexes. Required for normal neuromuscular synaptogenesis, axon pathfinding and neuronal migration (By similarity). Plays a role in the regulation of neurotransmission at mature neurons (By similarity). May controls synaptic activity by controlling UNC13A via ubiquitin dependent pathway (By similarity). Specifically recognizes TP73, promoting its ubiquitination and degradation.

    Poids moléculaire

    30633

    UniProt

    P0C2W1
Vous êtes ici:
Chat with us!